Adrian Hepner - Dec 28, 2022 Form 3 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Chief Medical Officer
Signature
/s/ David Snyder, Attorney-in-Fact
Stock symbol
COYA
Transactions as of
Dec 28, 2022
Transactions value $
$0
Form type
3
Date filed
12/28/2022, 07:38 PM
Next filing
Jan 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding COYA Stock Option (right to buy) Dec 28, 2022 Common Stock, par value $0.0001 per share 44K $1.09 Direct F1, F2
holding COYA Stock Option (right to buy) Dec 28, 2022 Common Stock, par value $0.0001 per share 43.9K $3.47 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the shares underlying the option vested on November 1, 2022, and the remaining shares will vest in 12 equal monthly installments beginning on December 1, 2022.
F2 The shares reported reflect the 1 for 5.6955 stock split effected December 12, 2022.

Remarks:

Exhibit 24--Power of Attorney